Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001204717 | SCV001375936 | pathogenic | not provided | 2023-10-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1730*) in the COL7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). This variant is present in population databases (rs746053763, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with epidermolysis bullosa dystrophica (PMID: 10504458). ClinVar contains an entry for this variant (Variation ID: 936007). For these reasons, this variant has been classified as Pathogenic. |
Biomedical Innovation Departament, |
RCV001352852 | SCV001547318 | pathogenic | Epidermolysis bullosa dystrophica | 2015-04-30 | criteria provided, single submitter | research | |
Foundation for Research in Genetics and Endocrinology, |
RCV003148946 | SCV003806430 | pathogenic | Recessive dystrophic epidermolysis bullosa | 2023-02-03 | criteria provided, single submitter | clinical testing | A homozygous nonsense variation in exon 59 of the COL7A1 gene that results in a stop codon and premature truncation of the protein at codon 1730 (p.Arg1730Ter) was detected. This variant has not been reported in the 1000 genomes and gnomAD databases. The in silico prediction of the variant is damaging by MuationTaster2. The reference codon is conserved across mammals. In summary, the variant meets our criteria to be classified as pathogenic. |